Socioeconomic and racial disparities in survival for patients with stage IV cancer.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Excerpta Medica Country of Publication: United States NLM ID: 0370473 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1883 (Electronic) Linking ISSN: 00029610 NLM ISO Abbreviation: Am J Surg Subsets: MEDLINE
    • Publication Information:
      Publication: Belle Mead, NJ : Excerpta Medica
      Original Publication: New York.
    • Subject Terms:
      Medicare* ; Prostatic Neoplasms*; Male ; Humans ; Aged ; United States/epidemiology ; Racial Groups ; Socioeconomic Factors ; Healthcare Disparities ; White
    • Abstract:
      Background: Disparities in cancer outcomes for minoritized people and groups experiencing disadvantages with Stage IV cancer is largely unknown.
      Methods: Patients with Stage IV pancreatic, colorectal, lung, breast, and prostate cancer were identified from 2004 to 2015 in the National Cancer Database. Cox proportional hazard models were used to quantify how demographics and treatments received were associated with overall survival.
      Results: 903,151 patients were included. Patients who were younger, non-Hispanic White, had private insurance, higher income, or received care at an academic center were more likely to receive surgery, chemotherapy, and/or radiation therapy (p < 0.001). Black patients, those with Medicare, Medicaid, no insurance, and lower income had lower survival rates across all five cancer types (p < 0.001). On multivariable analysis, receipt of surgery, radiation, and chemotherapy attenuated but did not eliminate this worse survival (p < 0.001).
      Conclusions: Survival for patients with Stage IV cancer differs by socioeconomic and self-reported racial classifications.
      Competing Interests: Declaration of competing interest The authors have no conflicts of interest to disclose.
      (Copyright © 2023 Elsevier Inc. All rights reserved.)
    • Comments:
      Comment in: Am J Surg. 2023 Jul;226(1):19. (PMID: 37095042)
    • Contributed Indexing:
      Keywords: Minoritized; Outcomes; Stage IV cancer; Survival; Treatment disparities
    • Publication Date:
      Date Created: 20230315 Date Completed: 20230621 Latest Revision: 20230621
    • Publication Date:
      20230621
    • Accession Number:
      10.1016/j.amjsurg.2023.03.003
    • Accession Number:
      36922322